Sponsor or institution
Clinical trials and research at Keimyung University Dongsan Medical Center
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Keimyung University Dongsan Medical Center that are recruiting, in South Korea. By phase: Phase 4 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
All recruiting trials (9)
-
BDNF Levels in Spine Pain Patients and Disc Degeneration
This observational study tests whether blood levels of BDNF relate to disc degeneration and inflammation in people with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Relationship between Periostin and ODI/Quality of Life in Lumbar Disc Disease
This study tests whether levels of periostin in the blood correlate with disability and quality of life measures in people with lumbar disc disease.
-
Effect of NSAIDs on a blood marker (serum periostin) in people with back disc problems
Researchers are testing whether taking NSAIDs influences serum periostin levels in patients with intervertebral disc problems and related back pain.
-
Stepwise withdrawal of ARNI and SGLT2i in HF with normalized ejection fraction
This trial tests whether gradually stopping ARNI and SGLT2i is safe for people whose heart function has recovered after fixing a reversible heart‑disease cause.
-
Ring-style blood pressure bracelet test compared with 24-hour monitoring in people with HFrEF
A ring-type blood pressure device is being tested to see if its 24-hour readings match those from standard ambulatory monitoring in adults with heart failure and reduced ejection fraction.
-
Delayed Start of ARNI and SGLT2 Inhibitor in Recovered Heart Failure After Correctable Causes
This pilot study tests whether delaying ARNI and SGLT2 inhibitors in patients whose heart function recovers after fixing a correctable cause is safe and feasible.
-
Allogeneic stem cell transplantation for relapsed T- and NK/T-cell lymphomas
This study is testing a new, less harmful treatment using stem cell transplants for people with T- and NK/T-cell lymphomas that have come back or didn’t get better with other treatments.
Quick answers
How many clinical trials run by Keimyung University Dongsan Medical Center are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.